{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:05:45Z","timestamp":1769745945367,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00482-020-00465-x","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T14:03:57Z","timestamp":1588601037000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Schmerztherapie bei Sichelzellkrankheit","Pain management in sickle cell disease"],"prefix":"10.1007","volume":"34","author":[{"given":"T.","family":"Rasche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"465_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware\u00a0RE, de Montalembert\u00a0M, Tshilolo\u00a0L, Abboud\u00a0MR (2017) Sickle cell disease. Lancet 390:311\u2013323","journal-title":"Lancet"},{"key":"465_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","volume":"337","author":"HF Bunn","year":"1997","unstructured":"Bunn\u00a0HF (1997) Pathogenesis and treatment of sickle cell disease. N\u00a0Engl J Med 337:762\u2013769","journal-title":"N Engl J Med"},{"key":"465_CR3","volume-title":"Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin","author":"H Baum","year":"2019","unstructured":"Baum\u00a0H (2019) Sichelzelle. In: Gressner\u00a0AM, Arndt\u00a0T (Hrsg) Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin. Springer, Berlin, Heidelberg"},{"key":"465_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees\u00a0DC, Williams\u00a0TN, Gladwin\u00a0MT (2010) Sickle-cell disease. Lancet 376:2018\u20132031","journal-title":"Lancet"},{"key":"465_CR5","unstructured":"Sichelzellkrankheit \u2013 AWMF-Leitlinie."},{"key":"465_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/003335491312800206","volume":"128","author":"S Lanzkron","year":"2013","unstructured":"Lanzkron\u00a0S, Carroll\u00a0CP, Haywood\u00a0C (2013) Mortality rates and age at death from sickle cell disease: U.S., 1979\u20132005. Public Health Rep 128:110\u2013116","journal-title":"Public Health Rep"},{"key":"465_CR7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V130.Suppl_1.865.865","volume":"130","author":"AB Payne","year":"2017","unstructured":"Payne\u00a0AB, Mehal\u00a0JM, Chapman\u00a0C, Haberling\u00a0DL, Richardson\u00a0LC, Bean\u00a0CJ, Hooper\u00a0WC (2017) Mortality trends and causes of death in persons with sickle cell disease in the United States, 1979\u20132014. Blood 130:865\u2013865","journal-title":"Blood"},{"key":"465_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt\u00a0OS, Brambilla\u00a0DJ, Rosse\u00a0WF, Milner\u00a0PF, Castro\u00a0O, Steinberg\u00a0MH, Klug\u00a0PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N\u00a0Engl J Med 330:1639\u20131644","journal-title":"N Engl J Med"},{"key":"465_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ncomms1104","volume":"1","author":"FB Piel","year":"2010","unstructured":"Piel\u00a0FB, Patil\u00a0AP, Howes\u00a0RE, Nyangiri\u00a0OA, Gething\u00a0PW, Williams\u00a0TN, Weatherall\u00a0DJ, Hay\u00a0SI (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1:104","journal-title":"Nat Commun"},{"key":"465_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26550","author":"JB Kunz","year":"2017","unstructured":"Kunz\u00a0JB, Cario\u00a0H, Grosse\u00a0R, Jarisch\u00a0A, Lobitz\u00a0S, Kulozik\u00a0AE (2017) The epidemiology of sickle cell disease in Germany following recent large-scale immigration. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26550","journal-title":"Pediatr Blood Cancer"},{"key":"465_CR11","doi-asserted-by":"publisher","first-page":"a011783","DOI":"10.1101\/cshperspect.a011783","volume":"3","author":"GR Serjeant","year":"2013","unstructured":"Serjeant\u00a0GR (2013) The natural history of sickle cell disease. Cold Spring Harb Perspect Med 3:a11783","journal-title":"Cold Spring Harb Perspect Med."},{"key":"465_CR12","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","volume":"387","author":"MT Gladwin","year":"2016","unstructured":"Gladwin\u00a0MT (2016) Cardiovascular complications and risk of death in sickle-cell disease. Lancet 387:2565\u20132574","journal-title":"Lancet"},{"key":"465_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.21905","volume":"86","author":"C Dampier","year":"2011","unstructured":"Dampier\u00a0C, LeBeau\u00a0P, Rhee\u00a0S, Lieff\u00a0S, Kesler\u00a0K, Ballas\u00a0S, Rogers\u00a0Z, Wang\u00a0W, Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium (CTC) Site Investigators (2011) Health-related quality of life in adults with sickle cell disease (SCD): a\u00a0report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 86:203\u2013205","journal-title":"Am J Hematol"},{"key":"465_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt\u00a0OS, Thorington\u00a0BD, Brambilla\u00a0DJ, Milner\u00a0PF, Rosse\u00a0WF, Vichinsky\u00a0E, Kinney\u00a0TR (1991) Pain in sickle cell disease. Rates and risk factors. N\u00a0Engl J Med 325:11\u201316","journal-title":"N Engl J Med"},{"key":"465_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MOH.0000000000000491","volume":"26","author":"A Aich","year":"2019","unstructured":"Aich\u00a0A, Jones\u00a0MK, Gupta\u00a0K (2019) Pain and sickle cell disease. Curr Opin Hematol 26:131\u2013138","journal-title":"Curr Opin Hematol"},{"key":"465_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101690","author":"S Veluswamy","year":"2019","unstructured":"Veluswamy\u00a0S, Shah\u00a0P, Denton\u00a0CC, Chalacheva\u00a0P, Khoo\u00a0MCK, Coates\u00a0TD (2019) Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger? J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm8101690","journal-title":"J Clin Med"},{"key":"465_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","volume":"148","author":"WR Smith","year":"2008","unstructured":"Smith\u00a0WR, Penberthy\u00a0LT, Bovbjerg\u00a0VE, McClish\u00a0DK, Roberts\u00a0JD, Dahman\u00a0B, Aisiku\u00a0IP, Levenson\u00a0JL, Roseff\u00a0SD (2008) Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 148:94\u2013101","journal-title":"Ann Intern Med"},{"key":"465_CR18","doi-asserted-by":"publisher","first-page":"134471","DOI":"10.1016\/j.neulet.2019.134471","volume":"712","author":"S Du","year":"2019","unstructured":"Du\u00a0S, Lin\u00a0C, Tao\u00a0Y\u2011X (2019) Updated mechanisms underlying sickle cell disease-associated pain. Neurosci Lett 712:134471","journal-title":"Neurosci Lett"},{"key":"465_CR19","doi-asserted-by":"publisher","first-page":"134445","DOI":"10.1016\/j.neulet.2019.134445","volume":"714","author":"D Sharma","year":"2019","unstructured":"Sharma\u00a0D, Brandow\u00a0AM (2019) Neuropathic pain in individuals with sickle cell disease. Neurosci Lett 714:134445","journal-title":"Neurosci Lett"},{"key":"465_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13023-019-1082-9","volume":"14","author":"FD Antunes","year":"2019","unstructured":"Antunes\u00a0FD, Junior\u00a0SCL, Cerqueira\u00a0KS, do Livramento Faro\u00a0M, Cipolotti\u00a0R (2019) Screening for neuropathic pain in patients with sickle cell disease: is a\u00a0single assessment scale sufficient? Orphanet J Rare Dis 14:108","journal-title":"Orphanet J Rare Dis"},{"key":"465_CR21","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","volume":"120","author":"SK Ballas","year":"2012","unstructured":"Ballas\u00a0SK, Gupta\u00a0K, Adams-Graves\u00a0P (2012) Sickle cell pain: a\u00a0critical reappraisal. Blood 120:3647\u20133656","journal-title":"Blood"},{"key":"465_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/iwj.12522","volume":"13","author":"IA Altman","year":"2016","unstructured":"Altman\u00a0IA, Kleinfelder\u00a0RE, Quigley\u00a0JG, Ennis\u00a0WJ, Minniti\u00a0CP (2016) A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease. Int Wound\u00a0J 13:1315\u20131324","journal-title":"Int Wound J"},{"key":"465_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jpain.2018.12.003","volume":"20","author":"JJ Field","year":"2019","unstructured":"Field\u00a0JJ, Ballas\u00a0SK, Campbell\u00a0CM, Crosby\u00a0LE, Dampier\u00a0C, Darbari\u00a0DS, McClish\u00a0DK, Smith\u00a0WR, Zempsky\u00a0WT (2019) AAAPT diagnostic criteria for acute sickle cell disease pain. J\u00a0Pain 20:746\u2013759","journal-title":"J Pain"},{"key":"465_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1302\/1863-2548.12.180094","volume":"13","author":"A Fontalis","year":"2019","unstructured":"Fontalis\u00a0A, Hughes\u00a0K, Nguyen\u00a0MP, Williamson\u00a0M, Yeo\u00a0A, Lui\u00a0D, Gelfer\u00a0Y (2019) The challenge of differentiating vaso-occlusive crises from osteomyelitis in children with sickle cell disease and bone pain: a 15-year retrospective review. J\u00a0Child Orthop 13:33\u201339","journal-title":"J Child Orthop"},{"key":"465_CR25","doi-asserted-by":"publisher","first-page":"e65001","DOI":"10.1371\/journal.pone.0065001","volume":"8","author":"BPD Inusa","year":"2013","unstructured":"Inusa\u00a0BPD, Oyewo\u00a0A, Brokke\u00a0F, Santhikumaran\u00a0G, Jogeesvaran\u00a0KH (2013) Dilemma in differentiating between acute osteomyelitis and bone infarction in children with sickle cell disease: the role of ultrasound. Plos One 8:e65001","journal-title":"Plos One"},{"key":"465_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pain.2009.06.029","volume":"145","author":"DK McClish","year":"2009","unstructured":"McClish\u00a0DK, Smith\u00a0WR, Dahman\u00a0BA, Levenson\u00a0JL, Roberts\u00a0JD, Penberthy\u00a0LT, Aisiku\u00a0IP, Roseff\u00a0SD, Bovbjerg\u00a0VE (2009) Pain site frequency and location in sickle cell disease: the PiSCES project. Pain 145:246\u2013251","journal-title":"Pain"},{"key":"465_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","volume":"18","author":"C Dampier","year":"2017","unstructured":"Dampier\u00a0C, Palermo\u00a0TM, Darbari\u00a0DS, Hassell\u00a0K, Smith\u00a0W, Zempsky\u00a0W (2017) AAPT diagnostic criteria for chronic sickle cell disease pain. J\u00a0Pain 18:490\u2013498","journal-title":"J Pain"},{"key":"465_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ajh.23575","volume":"88","author":"SK Ballas","year":"2013","unstructured":"Ballas\u00a0SK, Darbari\u00a0DS (2013) Neuropathy, neuropathic pain, and sickle cell disease. Am J Hematol 88:927\u2013929","journal-title":"Am J Hematol"},{"key":"465_CR29","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup\u00a0NB, Haroutounian\u00a0S, Kamerman\u00a0P et\u00a0al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157:1599\u20131606","journal-title":"Pain"},{"key":"465_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-015-0093-2","author":"M M\u00fccke","year":"2016","unstructured":"M\u00fccke\u00a0M, Cuhls\u00a0H, Radbruch\u00a0L, Baron\u00a0R, Maier\u00a0C, T\u00f6lle\u00a0T, Treede\u00a0R\u2011D, Rolke\u00a0R (2016) Quantitative sensory testing (QST). Schmerz. https:\/\/doi.org\/10.1007\/s00482-015-0093-2 (English version)","journal-title":"Schmerz"},{"key":"465_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1182\/asheducation-2017.1.534","volume":"2017","author":"DS Darbari","year":"2017","unstructured":"Darbari\u00a0DS, Brandow\u00a0AM (2017) Pain-measurement tools in sickle cell disease: where are we now? Hematology Am Soc Hematol Educ Program 2017:534\u2013541","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"465_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012187.pub2","author":"TE Cooper","year":"2019","unstructured":"Cooper\u00a0TE, Hambleton\u00a0IR, Ballas\u00a0SK, Johnston\u00a0BA, Wiffen\u00a0PJ (2019) Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012187.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"465_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00482-014-1463-x","volume":"29","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user\u00a0W, Bock\u00a0F, Engeser\u00a0P et al (2015) Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz 29:109\u2013130","journal-title":"Schmerz"},{"key":"465_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd011808.pub2","author":"T Aboursheid","year":"2019","unstructured":"Aboursheid\u00a0T, Albaroudi\u00a0O, Alahdab\u00a0F (2019) Inhaled nitric oxide for treating pain crises in people with sickle cell disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.cd011808.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"465_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd011358.pub3","author":"NN Than","year":"2019","unstructured":"Than\u00a0NN, Soe\u00a0HHK, Palaniappan\u00a0SK, Abas\u00a0AB, De Franceschi\u00a0L (2019) Magnesium for treating sickle cell disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.cd011358.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"465_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012943.pub2.","author":"MR Asnani","year":"2019","unstructured":"Asnani\u00a0MR, Francis\u00a0DK, Brandow\u00a0AM, Hammond Gabbadon\u00a0CE, Ali\u00a0A (2019) Interventions for treating neuropathic pain in people with sickle cell disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012943.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"465_CR37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1182\/blood.V99.3.1096","volume":"99","author":"SK Ballas","year":"2002","unstructured":"Ballas\u00a0SK (2002) Treatment of painful sickle cell leg ulcers with topical opioids. Blood 99:1096","journal-title":"Blood"},{"key":"465_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3324\/haematol.2018.211391","volume":"105","author":"P Shah","year":"2020","unstructured":"Shah\u00a0P, Khaleel\u00a0M, Thuptimdang\u00a0W et\u00a0al (2020) Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls. Haematologica 105:83\u201390","journal-title":"Haematologica"},{"key":"465_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPH.0b013e3181d869d5","volume":"32","author":"N Mahdi","year":"2010","unstructured":"Mahdi\u00a0N, Al-Ola\u00a0K, Khalek\u00a0NA, Almawi\u00a0WY (2010) Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J\u00a0Pediatr Hematol Oncol 32:345\u2013349","journal-title":"J Pediatr Hematol Oncol"},{"key":"465_CR40","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1097\/j.pain.0000000000001591","volume":"160","author":"JT Da Silva","year":"2019","unstructured":"Da Silva\u00a0JT, Letzen\u00a0JE, Haythornthwaite\u00a0JA, Finan\u00a0PH, Campbell\u00a0CM, Seminowicz\u00a0DA (2019) Do chronic pain and comorbidities affect brain function in sickle cell patients? A systematic review of neuroimaging and treatment approaches. Pain 160:1933\u20131945","journal-title":"Pain"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-020-00465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-020-00465-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-020-00465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:05:55Z","timestamp":1620086755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-020-00465-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1007\/s00482-020-00465-x","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"4 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>T.\u00a0Rasche<\/b>: A.\u00a0Finanzielle Interessen: T.\u00a0Rasche gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Medizinstudent, Universit\u00e4t Bonn, Stelle als studentische Hilfskraft am Zentrum f\u00fcr seltene Erkrankungen (ZSEB; bis 03\/2019). <b>D.\u00a0Emmert<\/b>: A.\u00a0Finanzielle Interessen: D.\u00a0Emmert gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Studentische Hilfskraft am Zentrum f\u00fcr seltene Erkrankungen (ZSEB) in Bonn (bis 03\/2019), Student Humanmedizin im praktischen Jahr, Universit\u00e4tsklinikum Bonn. <b>H.\u00a0Seidel<\/b>: A.\u00a0Finanzielle Interessen: H.\u00a0Seidel gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Internist in Bonn und Transfusionsmediziner in Dortmund, Centrum f\u00fcr Blutgerinnungsst\u00f6rungen (CBT) in Bonn und Dortmund | Mitgliedschaften: Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung (GTH), Deutsche Gesellschaft f\u00fcr Transfusionsmedizin und Immunh\u00e4matologie (DGTI), Berufsverband der Deutschen H\u00e4mostaseologen (BDDH) und International Society on Thrombosis and Haemostasis (ISTH). <b>J.\u00a0Sellin<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0Sellin gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Wissenschaftliche Angestellte, Zentrum f\u00fcr seltene Erkrankungen, Bonn | Mitgliedschaften: Gesellschaft f\u00fcr Biochemie und Molekularbiologie (GBM), Deutsche Zoologische Gesellschaft (DZG), Deutscher Hochschulverband (DHV). <b>R.\u00a0Conrad<\/b>: A.\u00a0Finanzielle Interessen: R.\u00a0Conrad gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt und Forschungsleiter in der Klinik und Poliklinik f\u00fcr Psychosomatische Medizin und Psychotherapie, Universit\u00e4tsklinikum Bonn | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Hypnose (DGH), Deutsches Kollegium f\u00fcr Psychosomatische Medizin (DKPM), Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). <b>M.\u00a0M\u00fccke<\/b>: A.\u00a0Finanzielle Interessen: M.\u00a0M\u00fccke gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Leiter des Zentrums f\u00fcr Seltene Erkrankungen, Universit\u00e4tsklinikum Bonn | niedergelassener Allgemeinmediziner, Praxis PD Dr. M\u00fccke, Bonn | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM), Ad-hoc-Ausschuss \u201eAusbildung zum Arzt\/Hochschulen und Medizinische Fakult\u00e4ten\u201c der \u00c4rztekammer Nordrhein.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}